Vensica Medical is developing a needle-free, painless procedure for the delivery of Botox® to treat overactive bladder.
The market seeks a safe, painless method to deliver Botox into the bladder wall, without needles.
Vensica is developing an ultrasound catheter used to deliver Botox into the bladder wall painlessly and without the use of needles. The catheter leverages the known properties of ultrasound (opens pores in the tissue and “pushes” the drug through these pores). The procedure using Vensica’s system can be performed in the doctor’s office or clinic, without anesthesia. Read more about the idea behind Vensica’s system.
Founded: August 2014
Stage: Business development; signed term sheet for new investment by undisclosed strategic investor
Investor: The Trendlines Group
IP: Filed PCT application
Overactive bladder (OAB), characterized by the urgent need to urinate and involuntary loss of urine, has a negative impact on the quality of life. In 50% of the cases, medications are ineffective and often have significant side effects. In 2011, the FDA approved the use of Botox to treat OAB. This procedure is performed using a cystoscope (to visualize the interior of the bladder) and a needle to inject the Botox. While Botox has demonstrated effectiveness in treating OAB, the procedure is expensive, painful (20-30 injection sites), risky (urinary tract infections), and in most cases performed under sedation.
OAB is the most common type of bladder disorder. There are an estimated 39 million people in the United States alone with OAB, and 4 million of them are unsatisfied with treatment.*
*W. Stuart Reynolds , Jay Fowke, Roger Dmochowski. The Burden of Overactive Bladder on US Public Health. Curr Bladder Dysfunct Rep. 2016 March. The Total Economic Burden of Overactive Bladder in the United States: A Disease Specific Approach. Am J Manag Care. 2009 March.
Watch CEO Avner Geva's interview on Israel Daily TV.
See Avner Geva's presentation at Trendlines 6th Annual Company Showcase.
Vensica's needle-free, painless procedure deliver Botox to the bladder wall to treat overactive bladder.
Minimally invasive treatment of heart valve disease
A more efficient ablation catheter to treat atrial fibrillation
Preventing the development of pressure sores
Novel treatment for vertebral compression fractures
Preventing catheter-associated urinary tract infections (CAUTIs)
Wireless, wearable vital sign monitoring system
Cryotherapy for superficial bladder cancer